• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

从卫生系统角度看药品的可及性。

Access to medicines from a health system perspective.

机构信息

Alliance for Health Policy and System Research, World Health Organization, Geneva, Switzerland. E-mail:

出版信息

Health Policy Plan. 2013 Oct;28(7):692-704. doi: 10.1093/heapol/czs108. Epub 2012 Nov 22.

DOI:10.1093/heapol/czs108
PMID:23174879
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3794462/
Abstract

Most health system strengthening interventions ignore interconnections between systems components. In particular, complex relationships between medicines and health financing, human resources, health information and service delivery are not given sufficient consideration. As a consequence, populations' access to medicines (ATM) is addressed mainly through fragmented, often vertical approaches usually focusing on supply, unrelated to the wider issue of access to health services and interventions. The objective of this article is to embed ATM in a health system perspective. For this purpose, we perform a structured literature review: we examine existing ATM frameworks, review determinants of ATM and define at which level of the health system they are likely to occur; we analyse to which extent existing ATM frameworks take into account access constraints at different levels of the health system. Our findings suggest that ATM barriers are complex and interconnected as they occur at multiple levels of the health system. Existing ATM frameworks only partially address the full range of ATM barriers. We propose three essential paradigm shifts that take into account complex and dynamic relationships between medicines and other components of the health system. A holistic view of demand-side constraints in tandem with consideration of multiple and dynamic relationships between medicines and other health system resources should be applied; it should be recognized that determinants of ATM are rooted in national, regional and international contexts. These are schematized in a new framework proposing a health system perspective on ATM.

摘要

大多数卫生系统强化干预措施都忽略了系统组成部分之间的相互联系。特别是,药品与卫生筹资、人力资源、卫生信息和服务提供之间的复杂关系没有得到充分考虑。因此,人们获取药品(ATM)主要通过零散的、通常是垂直的方法来解决,这些方法通常侧重于供应,与更广泛的获取卫生服务和干预措施的问题无关。本文的目的是从卫生系统的角度来嵌入 ATM。为此,我们进行了结构化文献综述:我们检查了现有的 ATM 框架,审查了 ATM 的决定因素,并确定了它们可能在卫生系统的哪个层面发生;我们分析了现有的 ATM 框架在多大程度上考虑了卫生系统不同层面的获取约束。我们的研究结果表明,ATM 障碍是复杂的和相互关联的,因为它们发生在卫生系统的多个层面。现有的 ATM 框架仅部分解决了 ATM 障碍的全部范围。我们提出了三个基本的范式转变,考虑到药品与卫生系统其他组成部分之间的复杂和动态关系。应该同时考虑需求方制约因素的整体观点,并考虑药品与其他卫生系统资源之间的多种和动态关系;应该认识到 ATM 的决定因素根植于国家、区域和国际背景。这些在一个新的框架中进行了图示化,提出了一个从卫生系统角度看待 ATM 的框架。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/22d4/3794462/4c4b99e2395a/czs108f2p.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/22d4/3794462/c5b89b000468/czs108f1p.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/22d4/3794462/4c4b99e2395a/czs108f2p.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/22d4/3794462/c5b89b000468/czs108f1p.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/22d4/3794462/4c4b99e2395a/czs108f2p.jpg

相似文献

1
Access to medicines from a health system perspective.从卫生系统角度看药品的可及性。
Health Policy Plan. 2013 Oct;28(7):692-704. doi: 10.1093/heapol/czs108. Epub 2012 Nov 22.
2
Frontline health workers as brokers: provider perceptions, experiences and mitigating strategies to improve access to essential medicines in South Africa.一线卫生工作者作为中间人:南非提供者对改善基本药物获取的认知、经验及缓解策略
BMC Health Serv Res. 2014 Nov 5;14:520. doi: 10.1186/s12913-014-0520-6.
3
International assistance and cooperation for access to essential medicines.获取基本药物的国际援助与合作。
Health Hum Rights. 2010 Jun 15;12(1):73-81.
4
A proposed analytical framework for qualitative evaluation of access to medicines from a health systems perspective.从卫生系统角度定性评估药品可及性的分析框架建议。
BMC Res Notes. 2024 Jun 7;17(1):159. doi: 10.1186/s13104-024-06764-1.
5
Tuberculosis结核病
6
Essential surgery: Integral to the right to health.基本外科:健康权的组成部分。
Health Hum Rights. 2010 Jun 15;12(1):137-52.
7
Improving access to medicines via the Health Impact Fund in India: a stakeholder analysis.通过印度健康影响基金改善药品可及性:利益相关者分析
Glob Health Action. 2018;11(1):1434935. doi: 10.1080/16549716.2018.1434935.
8
Analyzing implementation dynamics using theory-driven evaluation principles: lessons learnt from a South African centralized chronic dispensing model.运用理论驱动的评估原则分析实施动态:从南非集中式慢性疾病配药模式中吸取的经验教训。
BMC Health Serv Res. 2017 Dec 4;17(Suppl 2):724. doi: 10.1186/s12913-017-2640-2.
9
Health policy and systems research in access to medicines: a prioritized agenda for low- and middle-income countries.获取药品方面的卫生政策与系统研究:低收入和中等收入国家的优先议程。
Health Res Policy Syst. 2013 Oct 14;11:37. doi: 10.1186/1478-4505-11-37.
10
Beyond the black stump: rapid reviews of health research issues affecting regional, rural and remote Australia.超越黑木树:影响澳大利亚地区、农村和偏远地区的健康研究问题的快速综述。
Med J Aust. 2020 Dec;213 Suppl 11:S3-S32.e1. doi: 10.5694/mja2.50881.

引用本文的文献

1
WHF Roadmap on Single Pill Combination Therapies.世界心力衰竭学会单一片剂联合疗法路线图
Glob Heart. 2025 Aug 29;20(1):73. doi: 10.5334/gh.1457. eCollection 2025.
2
Bridging the Regulatory Divide: A Dual-Pathway Framework Using SRA Approvals and AI Evaluation to Ensure Drug Quality in Developing Countries.弥合监管差距:一种利用SRA批准和人工智能评估的双路径框架,以确保发展中国家的药品质量。
Pharmaceuticals (Basel). 2025 Jul 10;18(7):1024. doi: 10.3390/ph18071024.
3
The patient 'must find his own way': public policies concerning access to medicines in Angola.

本文引用的文献

1
The primacy of public health considerations in defining poor quality medicines.优先考虑公共卫生因素来定义劣质药品。
PLoS Med. 2011 Dec;8(12):e1001139. doi: 10.1371/journal.pmed.1001139. Epub 2011 Dec 6.
2
Trends in health policy and systems research over the past decade: still too little capacity in low-income countries.过去十年中卫生政策和体系研究的趋势:低收入国家的能力仍然严重不足。
PLoS One. 2011;6(11):e27263. doi: 10.1371/journal.pone.0027263. Epub 2011 Nov 22.
3
The growing caseload of chronic life-long conditions calls for a move towards full self-management in low-income countries.
患者“必须找到自己的途径”:安哥拉有关药品获取的公共政策
J Pharm Policy Pract. 2025 Jul 2;18(1):2521429. doi: 10.1080/20523211.2025.2521429. eCollection 2025.
4
Revisiting the issue of access to medicines in Africa: Challenges and recommendations.重新审视非洲药品获取问题:挑战与建议。
Public Health Chall. 2022 Jun 15;1(2):e9. doi: 10.1002/puh2.9. eCollection 2022 Jun.
5
Key stakeholders' views on the causes of medicine stock-outs in Mauritania: A qualitative study.毛里塔尼亚关键利益相关者对药品缺货原因的看法:一项定性研究。
PLoS One. 2025 May 27;20(5):e0304930. doi: 10.1371/journal.pone.0304930. eCollection 2025.
6
The Political Economy of the World Health Organization Model Lists of Essential Medicines.世界卫生组织基本药物示范清单的政治经济学
Milbank Q. 2025 Mar;103(1):52-99. doi: 10.1111/1468-0009.70001. Epub 2025 Feb 27.
7
Assessment of out-of-pocket (OOP) expenditures on essential medicines for acute and chronic illness: a comparative study across regional and socioeconomic groups in India.印度急性和慢性病基本药物自付费用评估:跨地区和社会经济群体的比较研究
BMC Public Health. 2025 Jan 29;25(1):373. doi: 10.1186/s12889-025-21312-7.
8
Supervision, performance assessment, and recognition strategy (SPARS) - a multipronged strategy to strengthen medicines management in Nepal: pilot study methods and baseline results.监督、绩效评估与认可策略(SPARS)——尼泊尔加强药品管理的多管齐下策略:试点研究方法与基线结果
J Pharm Policy Pract. 2025 Jan 20;18(1):2449043. doi: 10.1080/20523211.2024.2449043. eCollection 2025.
9
Establishing links between drug registers and essential medicines lists.在药品登记册与基本药物清单之间建立联系。
Bull World Health Organ. 2025 Jan 1;103(1):37-42. doi: 10.2471/BLT.24.291512. Epub 2024 Oct 29.
10
Costs of the Supervision, Performance Assessment and Recognition Strategy (SPARS) for improving medicines management in Nepal.尼泊尔用于改善药品管理的监督、绩效评估与认可战略(SPARS)的成本。
J Pharm Policy Pract. 2024 Nov 18;17(1):2421258. doi: 10.1080/20523211.2024.2421258. eCollection 2024.
慢性病患者人数不断增加,这就要求在低收入国家转向全面的自我管理。
Global Health. 2011 Oct 10;7:38. doi: 10.1186/1744-8603-7-38.
4
Building the field of health policy and systems research: framing the questions.构建卫生政策和体系研究领域:确定研究问题。
PLoS Med. 2011 Aug;8(8):e1001073. doi: 10.1371/journal.pmed.1001073. Epub 2011 Aug 16.
5
Understanding pathways for scaling up health services through the lens of complex adaptive systems.理解通过复杂适应系统视角扩大卫生服务规模的途径。
Health Policy Plan. 2012 Aug;27(5):365-73. doi: 10.1093/heapol/czr054. Epub 2011 Aug 5.
6
Composition of pluralistic health systems: how much can we learn from household surveys? An exploration in Cambodia.多元卫生系统构成:我们能从家庭调查中学到多少?柬埔寨的探索。
Health Policy Plan. 2011 Jul;26 Suppl 1:i30-44. doi: 10.1093/heapol/czr026.
7
Addressing access barriers to health services: an analytical framework for selecting appropriate interventions in low-income Asian countries.解决卫生服务获取障碍:选择低收入亚洲国家适宜干预措施的分析框架。
Health Policy Plan. 2012 Jul;27(4):288-300. doi: 10.1093/heapol/czr038. Epub 2011 May 12.
8
Access to essential medicines in national constitutions.国家宪法中基本药物的获取。
Bull World Health Organ. 2010 Nov 1;88(11):800. doi: 10.2471/BLT.10.078733.
9
The real cost of counterfeit medicines.假药的真实成本。
Lancet Infect Dis. 2010 Sep;10(9):585-6. doi: 10.1016/s1473-3099(10)70173-0.
10
Access to maternal and perinatal health services: lessons from successful and less successful examples of improving access to safe delivery and care of the newborn.获得孕产妇和围产期保健服务:改善安全分娩和新生儿护理获取途径的成功和不太成功案例的经验教训。
Trop Med Int Health. 2010 Aug;15(8):901-9. doi: 10.1111/j.1365-3156.2010.02558.x. Epub 2010 Jun 9.